Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India To Weed Out Over 300 Fixed-Dose Combos; Next Round In Court

This article was originally published in Scrip

Executive Summary

India has clamped down on the country's burgeoning market for irrational fixed-dose combinations (FDCs), weeding out more than 300 such products – a move that is seen as denting the industry sharply but being welcomed by physicians given the lack of therapeutic rationale for most of these medicines and the growing challenge of drug resistance in the case of anti-infectives.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register